United Orthopedic Corporation (TPEX:4129)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
104.50
+1.00 (0.97%)
Mar 5, 2026, 1:30 PM CST
12.61%
Market Cap 9.98B
Revenue (ttm) 5.46B
Net Income (ttm) 553.45M
Shares Out 96.44M
EPS (ttm) 5.66
PE Ratio 18.29
Forward PE 15.36
Dividend 4.00 (3.76%)
Ex-Dividend Date Jul 23, 2025
Volume 1,000
Average Volume 209,528
Open 104.00
Previous Close 103.50
Day's Range 104.00 - 106.00
52-Week Range 77.30 - 131.50
Beta 0.48
RSI 32.23
Earnings Date Mar 24, 2026

About United Orthopedic

United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments in Taiwan, Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial knee joints, including artificial knee replacement joints, revision knee replacement systems, restricted artificial knee joints, and customized artificia... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1993
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4129
Full Company Profile

Financial Performance

In 2024, United Orthopedic's revenue was 4.65 billion, an increase of 18.40% compared to the previous year's 3.93 billion. Earnings were 455.96 million, an increase of 20.11%.

Financial Statements

News

There is no news available yet.